Yesterday afternoon the "Journal of the American Medical Association" (JAMA) published a study showing that cheaper, generic heart drugs work just as well as more expensive, brand-name heart drugs... Read More

In a special edition 'Outrage of the Day,' Cramer has not one, but two gripes on his mind: one personal and one business, which is the one he decides to start with, since "we're not about making friends on this show, we're about making money."... Read More

When drug companies choose bullish, optimistic-sounding acronyms for clinical trials they should, perhaps, choose more wisely lest they backfire when the tests don't turn out like they hope they will... Read More

According to the "National Changing Diabetes Program" which is sponsored by NVO, the "widely accepted" figure has been $174 billion... Read More

How do US tax payers feel about supporting the liquidity of Dutch insurer Aegon? ... Read More